125 related articles for article (PubMed ID: 1391450)
1. Preparation, properties and biological function of liposome encapsulated hemoglobin.
Domokos G; Jopski B; Schmidt KH
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):345-54. PubMed ID: 1391450
[No Abstract] [Full Text] [Related]
2. Liposome-encapsulated hemoglobin processing methods.
Zheng S; Zheng Y; Beissinger RL; Fresco R
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):355-64. PubMed ID: 1391451
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, physical properties and pharmacokinetics of sterically-stabilized liposome-encapsulated hemoglobin.
Zheng S; Zheng Y; Beissinger R
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):487-501. PubMed ID: 7994371
[TBL] [Abstract][Full Text] [Related]
4. Large-scale blood substitute production using a microfluidizer.
Vivier A; Vuillemard JC; Ackermann HW; Poncelet D
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):377-97. PubMed ID: 1391454
[TBL] [Abstract][Full Text] [Related]
5. Circulation persistence and biodistribution of lyophilized liposome-encapsulated hemoglobin: an oxygen-carrying resuscitative fluid.
Rudolph AS; Cliff RO; Klipper R; Goins B; Phillips WT
Crit Care Med; 1994 Jan; 22(1):142-50. PubMed ID: 8124957
[TBL] [Abstract][Full Text] [Related]
6. Oxygen-transport and solution properties of polylipid/Hb vesicles (ARC).
Takeoka S; Hasegawa E; Nishide H; Tsuchida E; Sekiguchi S
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):399-404. PubMed ID: 1391455
[TBL] [Abstract][Full Text] [Related]
7. Stabilized hemoglobin vesicles.
Tsuchida E
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):467-77. PubMed ID: 7994369
[TBL] [Abstract][Full Text] [Related]
8. Interactions of liposome encapsulated hemoglobin and phosphate buffer liposomes with neutrophilic granulocytes and plasma.
Domokos G; Tauber G; Schmidt KH
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):761-70. PubMed ID: 1391509
[No Abstract] [Full Text] [Related]
9. Preparation of carboxymethylchitin-incorporated submicron bilayer-lipid membrane artificial cells (liposomes) encapsulating hemoglobin.
Mobed M; Nishiya T; Chang TM
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):365-8. PubMed ID: 1391452
[No Abstract] [Full Text] [Related]
10. Preparation and characterization of crosslinked and polymerized hemoglobin solutions.
Bakker JC; Berbers GA; Bleeker WK; den Boer PJ; Biessels PT
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):233-41. PubMed ID: 1391437
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of diaspirin cross-linked hemoglobin solutions for preclinical studies.
Nelson D; Azari M; Brown R; Burhop K; Bush S; Catarello J; Chuang H; Downing C; Estep T; Loewen A
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):423-7. PubMed ID: 1391458
[TBL] [Abstract][Full Text] [Related]
12. Progress in development of synthetic erythrocytes made by encapsulation of hemoglobin.
Djordjevich L; Ivankovich AD
Adv Exp Med Biol; 1988; 238():171-97. PubMed ID: 3074636
[No Abstract] [Full Text] [Related]
13. Cross linking encapsulated hemoglobin with solid phase supports: lipid enveloped hemoglobin adsorbed to surface modified ceramic particles exhibit physiological oxygen lability.
Kossovsky N; Gelman A; Sponsler E
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):479-85. PubMed ID: 7994370
[TBL] [Abstract][Full Text] [Related]
14. A novel liposome-encapsulated hemoglobin/silica nanoparticle as an oxygen carrier.
Liu M; Gan L; Chen L; Zhu D; Xu Z; Hao Z; Chen L
Int J Pharm; 2012 May; 427(2):354-7. PubMed ID: 22348875
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of hemoglobin in non-phospholipid vesicles.
Vandegriff KD; Wallach DF; Winslow RM
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):849-54. PubMed ID: 7994408
[TBL] [Abstract][Full Text] [Related]
16. Liposome-encapsulated hemoglobin as a red cell surrogate. Preparation scale-up.
Beissinger RL; Farmer MC; Gossage JL
ASAIO Trans; 1986; 32(1):58-63. PubMed ID: 3778774
[No Abstract] [Full Text] [Related]
17. Production of PEG-modified bovine hemoglobin: economics and feasibility.
Bradley R; Sloshberg S; Nho K; Czuba B; Szesko D; Shorr R
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):657-67. PubMed ID: 7994387
[TBL] [Abstract][Full Text] [Related]
18. [The physicochemical and biological properties of the bovine hemoglobin polymer].
Smirnov IV; Khachatur'ian AA; Fetisova LV; Ivanov IuG; Groznaia TG; Smirnova IL; Vorob'eva TM; Akimova TA; Iarochkin VS; Rozenberg GIa
Gematol Transfuziol; 1992; 37(7-8):15-7. PubMed ID: 1342977
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin tetramers stabilized with polyaspirins.
Bucci E; Fronticelli C; Razynska A; Militello V; Koehler R; Urbaitis B
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):243-52. PubMed ID: 1391438
[TBL] [Abstract][Full Text] [Related]
20. Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: a preliminary report.
Yu WP; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):889-93. PubMed ID: 7994414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
